November 01, 2017

Companion Diagnostic Expertise

Learn how we can ensure success in your next companion diagnostic development program
The development of biomarkers and companion diagnostics is an integral component in drug development programs, especially for personalized medicines. You need one global partner to help you simplify and align co-development strategies to speed development and increase the probability of regulatory and commercial success.

Download this infographic to learn more about how we provide customers an optimal path to co-develop their companion diagnostic with clinical development of the therapeutic, regulatory submission and market launch.

Related Services:
Companion Diagnostic Development: Current trends and recommendations

Companion Diagnostics

Extensive expertise to accelerate your tandem development pathway

Central Laboratory Considerations for Deploying a Global Companion Diagnostics Solution

World CDx Europe 2018

Read More